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INTRODUCTION
Excessive dietary sodium intake is known to 
be the most important factor contributing 
to the development of hypertension. Daily 
sodium requirement is approximately 0.5 g, 
and maximum recommended daily intake is 
1.5 g, corresponding to 3.8 g of salt [1]. The 
contribution of sodium to the pathogenesis 
of hypertension is primarily related to the 
phenomenon of sodium sensitivity. Its preva-
lence in the general Caucasian population is 
estimated at 20% but it approaches 50% in 
patients with hypertension. It is even more 
prevalent in South-Asian and African popula-
tions. Sodium sensitivity is closely related to 
the efficiency of renal mechanisms of sodium 
excretion, referred to as pressure natriuresis, 
which ultimately results in increased glo-
merular filtration rates (GFR) and inhibition 
of sodium and water reabsorption in renal 
tubules. Thus, elevated blood pressure (BP) 
associated with increased sodium intake is 
related to an impairment of the mechanisms 
that allow for increasing urinary sodium 
excretion per time unit [2].
One of the diagnostic methods of 
assessing sodium sensitivity of hyperten-
sion that has been known for many years 
and is currently increasingly applied in 
the research on sodium sensitivity is the 
measurement of sodium reabsorption in proximal and distal 
renal tubules using endogenous lithium clearance.
THE ROLE OF SODIUM  
IN THE PATHOGENESIS OF HYPERTENSION
In the populations of developed countries where the preva-
lence of hypertension is markedly higher than in develop-
ing countries, significant differences in the amounts of salt 
consumed in the diet have been observed. The INTERSALT 
study was the largest clinical trial which evaluated, among 
other parameters, salt intakes in various populations. It was 
conducted in 32 countries worldwide and included over 
10,000 adults aged from 20 to 59 years. A standardised 
method of assessment of daily sodium and potassium urinary 
excretion was used in all participating centres. Sodium excre-
tion varied markedly in respective groups and ranged from 
0.2 mmol/day to 242 mmol/day, thus indicating a substantial 
heterogeneity of the investigated populations [3].
Data on the deleterious effects of excess salt intake on 
the pathogenesis of hypertension comes from animal models 
and epidemiological studies. In chimpanzees fed with a very 
low-sodium and low-potassium vegetarian diet, an increase of 
dietary sodium to 10–15 g/day for 20 months was associated 
with a 33 mm Hg elevation of systolic blood pressure (SBP) 
[4]. Results of epidemiological studies also clearly indicated 
a positive correlation of sodium intake and SBP (but not 
diastolic blood pressure [DBP]) [5, 6]. Moreover, du Cailar et 
al. [7] demonstrated an independent correlation of increased 
sodium intake and elevated pulse pressure. On the other 
hand, a reduction of sodium intake results in lowering SBP 
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and pulse pressure, particularly in elderly patients with isolated 
systolic hypertension [6]. A meta-analysis of 56 clinical trials 
published in 1998 by Graudal et al. [8] revealed that reduction 
of sodium intake (defined on the basis of reduction of urinary 
sodium excretion by 100 mmol/L) in hypertensive subjects was 
associated with a statistically significant 3.7 mm Hg decrease 
of SBP and 0.9 mm Hg decrease of DBP. In normotensive 
subjects, the effect was significant only for SBP. The effects 
of diet on BP were also assessed in the DASH study (Dietary 
Approaches to Stop Hypertension) [9] and the TOHP study 
(The Trials of Hypertension Prevention) [10]. These studies 
demonstrated unequivocally that in order to decrease BP, it 
is necessary to reduce salt intake as well as to reduce calorie 
intake by limiting the consumption of saturated fats.
For a long time it was presumed that increased serum 
sodium levels cause the elevation of BP only due to increased 
blood volume and peripheral resistance resulting from struc-
tural and functional changes of arterioles. However, recent 
basic science research and population surveys have provided 
abundant evidence proving that sodium may contribute to 
end-organ cardiovascular and renal complications mediated 
by mechanisms independent of BP [11]. Remodelling of the 
walls of large arteries observed both in animal models and in 
humans is associated mainly with increased thickness of the 
tunica media and quantitative and structural alterations of 
collagen and elastin. In a study on spontaneously hypertensive 
rats (SHR), Et-Taoui et al. [12] observed that a high-sodium 
diet caused reduced hyaluronate contents in the wall of aorta 
and hyperplasia of the tunica media, leading to reduction of 
compliance of the walls of large arteries that was independent 
of average BP and of alterations of collagen and elastin con-
tents. Other studies on SHR have also revealed that increased 
dietary sodium intake was associated with vascular hypertro-
phy and remodelling which involved not only an increased 
tunica media thickness but also an elevated extracellular 
elastin and collagen contents in the aortal wall [13, 14]. In 
their pioneering study of a Chinese population, Avolio et al. 
[15] demonstrated that increased consumption of salt (13.3 g 
NaCl/day vs. 7.3 g NaCl/day) was associated with significantly 
higher stiffness of the aortal wall measured using the pulse 
wave velocity method, regardless of the age and BP of the sub-
jects. Other authors have also demonstrated a BP-independent 
influence of sodium on left ventricular hypertrophy [16] and 
impaired contractility of the left ventricle [17].
To date, the concept of sodium sensitivity of hypertension 
has been based on the traditional ‘two-compartment’ model 
(with intracellular sodium as one compartment and extracel-
lular sodium as another broad compartment, with a presumed 
lack of differences of sodium concentrations between various 
extracellular fluid compartments). However, this concept was 
significantly modified on the basis of experimental and clinical 
research by Titze et al. [18]. The authors revealed that anionic 
glycosaminoglycans, located predominantly in the skin, are 
able to accumulate significant amounts of sodium ions without 
subsequent accumulation of water; this proves the presence of 
the third, hyperosmolar ‘compartment’ accumulating sodium. 
This compartment might be a very important ‘buffer’ to the 
hypertensive activity of excess sodium acting by binding the 
ions that might be later released again in cases of sodium 
deficiency. According to this concept, sodium dependence of 
hypertension might develop not only due to renal mechanisms 
regulating water and electrolyte homeostasis, but also due to 
defective binding of excess sodium by glycosaminoglycans of 
connective tissue (extrarenal regulation). The release or reten-
tion of sodium in this compartment would be controlled by 
the connective tissue monocyte/macrophage system regulat-
ing the effectiveness of lymphatic drainage by the secreted 
cytokines [18–20]. This mechanism is also an argument in the 
criticism of measuring sodium intake solely on the basis of its 
daily urinary excretion. 
ENDOGENOUS LITHIUM CLEARANCE:  
METHODOLOGY
In clinical trials, several methods have been used for the evalu-
ation of water and sodium turnover. Luft et al. [21] observed 
that in population studies, daily urinary sodium excretion is 
an adequate measure of dietary sodium intake. Neverthe-
less, 24-h urine collection is associated with a relatively 
high measurement bias, usually resulting from an inaccurate 
sample collection.
In recent years, 24-h endogenous lithium clearance has 
become a method allowing for accurate estimation of renal 
sodium reabsorption free of measurement bias. Lithium ions 
undergo filtration in renal glomeruli, while their reabsorp-
tion takes place mainly in proximal tubules simultaneously 
to the reabsorption of water and sodium. Early studies on 
tubular sodium reabsorption using the endogenous lithium 
clearance method were conducted in the 1980s. Initially 
they were based on the assessment of endogenous clear-
ance of lithium administered in a form of carbonate [22]. 
Later, spectrophotometry was introduced in the methodo-
logy of the measurement of endogenous lithium clearance. 
This allowed for measuring sodium and water reabsorption 
without special preparation, based on the samples collected 
routinely for diagnostic tests. Lithium is naturally present in 
blood because of its wide presence in soil, water and foods, 
particularly vegetables and fruits. Serum levels of lithium vary 
in individual regions, and in persons without occupational or 
environmental exposure to excess levels of lithium, they range 
from 0.6 to 3.8 μg/L [23, 24], although they may sometimes 
be well outside these values [25]. Urine lithium levels may 
be one order of magnitude higher. 
The measurements of lithium clearance were based 
on the assumption that reabsorption of lithium takes place 
almost exclusively in proximal renal tubules, and that all the 
non-reabsorbed lithium ions are excreted with urine. Thus, 
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the measurements of serum and urinary lithium levels allow 
for the estimation of fractional lithium excretion (FELi). Because 
the transport of lithium ions through cellular membranes of 
the proximal renal tubule cells involves the same cellular 
mechanisms as the transport of sodium and water, FELi is a very 
accurate, glomerular filtration-dependent, marker of frac-
tional sodium reabsorption in proximal tubules (FENa). Thus, 
to calculate lithium and sodium reabsorption, it is necessary 
to assess six parameters: lithium concentration (sLi, uLi), so-
dium concentration (sNa, uNa) and creatinine concentration 
(sCR, uCR) in simultaneously collected serum and 24-h urine 
samples. Clearances are calculated as Cx = Ux × V/Px, where 
Ux and Px are the urinary and serum concentrations of the 
solute x, and V is the urine flow rate in millilitres per minute. 
High lithium clearance or a small difference between lithium 
and sodium clearances indicates a better ability to excrete 
sodium from the corresponding tubule, but does not depend 
on pressure natriuresis. The fractional excretion of sodium 
(FENa) is calculated using the formula: FENa = CNa (sodium 
clearance)/CCR (creatinine clearance) and the fractional excre-
tion of lithium (FELi) is calculated using an analogous formula: 
FELi = CLi (lithium clearance)/CCR (creatinine clearance), and 
expressed as a percentage. A higher FELi indicates that less 
sodium and water is reabsorbed in the proximal tubule and 
hence more sodium and water is cleared from the proximal 
tubule to the distal tubule [26].
The simultaneous calculations of FELi and FENa allow for the 
calculation of anestimated fractional distal sodium reabsorp-
tion (RNadist) according to the formula: RNadist = [(FELi – FENa)/ 
/FELi] × 100. RNadist  is an estimation of the amount of sodium 
that was not reabsorbed in proximal tubules, but its reabsorp-
tion took place in the distal renal tubules. Estimated fractional 
proximal sodium reabsorption (RNaprox) may be calculated 
according to the formula: RNaprox = 100 – FELi [27].
Samples for the measurements must be obtained in 
a way that excludes contamination with lithium from other 
sources. Moreover, a prerequisite for an accurate measure-
ment is maintaining a stable diet without high-lithium and 
high-sodium products for 1–2 weeks before the collection 
of the samples, as well as avoiding drugs that may affect the 
investigated processes (unless they are being researched). 
High lithium levels have been found in certain mineral waters 
[28] and food products from regions with high environmental 
lithium levels [29].
The measurements of serum and urinary lithium concen-
trations on the level of biological background are currently 
not a routine method and must be performed in specialist 
laboratories. Several spectrophotometric methods, ensuring 
high sensitivity and appropriate precision, are used. These 
include: flame injection (FI-AAS) and graphite furnace–atomic 
absorption spectrometry (GF-AAS), inductively coupled 
plasma–atomic emission spectrometry (ICP-AES), and low- or 
high-resolution inductively coupled plasma–mass spectro-
metry (ICP-MS). These methods require very small volume 
samples (of the order of 0.1 mL) and their recent refinements 
allow for measurement of the collected samples either im-
mediately [30, 31] or after minor preparation [32]. Their 
lower limit of detection is below 0.2 µg/L, and precision is 
below 10%. These methods are becoming increasingly avail-
able thanks to rapid technical progress and miniaturisation, 
resulting in lower costs of the analytical equipment.
FACTORS DETERMINING  
RENAL METABOLISM OF SODIUM
The processes of sodium excretion and reabsorption undergo 
a complex regulation in which several direct and indirect 
haemodynamic, genetic, hormonal, dietary and pharmaco-
logical factors are involved. Under physiological conditions, 
approximately 60–70% of sodium that has undergone filtration 
is reabsorbed on the level of proximal renal tubules, while 
as much as 90% of the remaining sodium load is reabsorbed 
in the distal portions of the nephron [33]. Numerous studies 
have demonstrated that reabsorption of sodium increases with 
age and is higher in males than in females [34], which was 
confirmed by the data obtained in large general population 
cohort (535 men vs. 534 women), in which significantly more 
effective sodium and lithium urinary excretion and higher 
FENa values were demonstrated in males [35]. With respect 
to ethnic differences, a study including families of European 
and African ethnicity revealed that the African subjects had 
significantly higher sodium reabsorption than the European 
subjects. Moreover, ethnic differences were observed with 
respect to the location of increased sodium reabsorption in 
the nephron: in persons of African ethnicity, it was located 
in proximal tubules, while in persons of European ethnicity, 
reabsorption of sodium was relatively more pronounced in 
the distal portions of the nephron. It has also been revealed 
that the inheritance of both phenotypes of sodium reabsorp-
tion (RNaprox and RNadist) is race-dependent [36]. In numerous 
studies, the association of overweight or obesity with increased 
reabsorption of sodium in proximal tubules was observed [35, 
37, 38]. Increased sodium reabsorption is one of the initial 
pathological phenomena associated with the development 
of hypertension in obese persons [39]. Several hormones 
released by adipose tissue (like leptin) are able to stimulate 
reabsorption of sodium in renal tubules both directly and 
indirectly (via stimulation of sympathetic hyperactivity which 
is typical for obesity), while other mediators synthesised by 
adipose tissue (e.g. 2,13-epoxy-9-keto-10(trans)-octadece-
noic acid [EKODE]) stimulate the secretion of aldosterone 
[40, 41]. Moreover, adipocytes are an important source of 
angiotensinogen, which is the basis of the significant effect 
of adipose tissue (particularly visceral) on the renin–angioten-
sin–aldosterone (RAA) axis [42].
Among the hormonal factors, the leading role in this 
complex process is played by angiotensin II (Ang II). Kidneys 
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contain many Ang II receptors, whose activation alters haemo-
dynamics, glomerular permeability and urinary electrolyte 
excretion. It has been demonstrated that intravenous or 
intraarterial infusion of Ang II causes a decrease of renal flow 
and subsequent reduction of GFR due to vasoconstriction, 
including, among others, the afferent and efferent arterioles 
of the nephron. Moreover, Ang II has direct effects on the 
glomerulus, causing reduction of the ultrafiltration index and 
GFR. These mechanisms, together with the direct effects of 
Ang II on renal tubules, lead to increased sodium reabsorp-
tion in proximal tubules. Angiotensin converting enzyme 
(ACE) inhibitors have opposite effects. Numerous studies 
have revealed that they increase renal blood flow (this ef-
fect is more pronounced in subjects with high activity of the 
RAA system, which is physiological in persons consuming 
a low-sodium diet), maintain GFR and decrease both total 
and fractional sodium reabsorption [43]. With respect to the 
sartans, Burnier et al. [44] performed a detailed review of 
the effects of single-dose 100 mg losartan vs. placebo on BP, 
haemodynamics and renal reabsorption of sodium (assessed 
using endogenous lithium clearance). The measurements 
were performed sequentially after six days of a high-sodium 
(200 mmol/day) and then a low-sodium (50 mmol/day) diet. In 
the losartan group, significant lowering of BP vs. placebo was 
observed, while there were no effects on GFR and renal blood 
flow, regardless of consuming a high-sodium or low-sodium 
diet. In the periods of consuming a low-sodium diet, signifi-
cant elevations of plasma renin activity (PRA) and serum Ang II 
and alodosterone levels were observed. Moreover, the effects 
of losartan on the analysed parameters (i.e. significantly higher 
elevation of PRA and Ang II levels and decreased aldosterone 
levels) were higher than in patients on a high-sodium diet. 
Nevertheless, the most interesting results were obtained for 
the parameters of urinary water and electrolyte excretion. It 
was demonstrated that in persons consuming a low-sodium 
diet, the administration of losartan caused a statistically sig-
nificant linear increase of 6-h urinary sodium excretion (up 
from 16.0 to 29.5 mmol), effectiveness of urinary sodium 
excretion (up from 115 to 207 µmol/min), and fractional 
urinary sodium excretion (up from 0.76 to 1.48%) compared 
to the values obtained before the administration of the drug. 
These trends were not observed in the placebo group. The 
spectrophotometrical measurements of endogenous lithium 
clearance revealed no differences in urinary lithium excretion 
rates, fractional lithium excretion or fractional proximal so-
dium reabsorption between the losartan and placebo groups, 
whereas a significant reduction of fractional distal sodium 
reabsorption was found in the losartan group. This may sug-
gest that distal renal tubules are the part of the nephron in 
which ACE inhibitors and sartans directly exert their activity. 
The results in the subjects consuming a high-sodium diet 
followed a trend similar to the group consuming a low-sodium 
diet, but they were much less apparent and did not reach 
statistical significance, thus suggesting a direct relationship 
between the RAA activity and the magnitude of the drug 
effect. Among other hormonal mechanisms of renal sodium 
reabsorption, much attention has been recently paid to the 
effects of dopamine which causes reduction of renal reabsorp-
tion of sodium mediated by G protein-dependent stimulation 
of Type 1 dopamine receptors (DRD1) located in the proximal 
tubules [27, 45].
ENDOGENOUS LITHIUM CLEARANCE  
AND THE PARAMETERS OF BLOOD PRESSURE, 
DAMAGE OF THE LARGE ARTERIES  
AND MYOCARDIAL REMODELLING
Numerous observational studies conducted in the 1990s indi-
cated an association between sodium turnover and elements 
of the RAA system and sodium-sensitivity of hypertension. All 
these studies were based on measurements of endogenous 
lithium clearance and they generally revealed a close rela-
tionship between increased sodium reabsorption in proximal 
renal tubules and hypertension. Fractional lithium excretion 
(FELi) and calculated fractional proximal sodium reabsorp-
tion (RNaprox) appeared to be markers of sodium sensitivity 
of hypertension independent of renal haemodynamics [26, 
46]. Moreover, their predictive value for the development 
of hypertension [47] and relationship with the increase of 
cardiovascular risk [48] were demonstrated. 
Among many studies covering this field, one — an Ital-
ian population study conducted within the Olivetti Heart 
Study project — became a breakthrough. The study included 
47 healthy subjects consuming a high-sodium diet (average 
sodium intake 185 mmol/day), in whom sodium in the diet 
was restricted to an average intake of 70 mmol/day for three 
days. In the periods of consuming the high-sodium diet, FENa 
values were significantly higher, while RNaprox and RNadist 
decreased significantly compared to the periods of consum-
ing the low-sodium diet. However, most interesting were 
the results in subgroups divided into tertiles according to 
the decrease of mean arterial pressure caused by the reduc-
tion of the dietary sodium intake. These revealed that the 
patients in whom the fall of mean BP was most pronounced 
(≥ 9.6 mm Hg vs. 9.6–3.9 mmHg vs. £ 3.9 mm Hg) had 
the least pronounced reduction of RNaprox caused by the 
changes of sodium consumption, which suggested a lack of 
flexibility of their sodium metabolism and a predisposition 
to the development of hypertension. Moreover, it revealed 
that a lack of adequate reduction of sodium reabsorption in 
proximal tubules was compensated for by a parallel increase 
of GFR [49]. These results were confirmed by another study 
by Chiolero et al. [50] including 38 patients with hypertension 
in whom the diet was changed from low-sodium (approxi-
mately 70 mmol/day) to high-sodium by adding an extra 6 g 
of NaCl/day to the standard diet. The analyses included the 
tertiles of ‘sodium-sensitivity’ of hypertension based on the 
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levels of reduction of mean arterial pressure resulting from 
dietary sodium restriction, with no reduction in the first tertile, 
4 mm Hg reduction in the second tertile, and 13 mm Hg 
reduction in the third tertile. In the group of patients with 
the largest BP reductions after dietary sodium restriction, 
a decrease of FELi values was observed, while in the first and 
third tertiles this parameter increased (third tertile from 24.7 to 
19.5% vs. second tertile from 18.6 to 19.1% vs. first tertile 
from 17.0 to 23.0%). The reverse correlation between the 
sodium load and FELi in the third tertile that was found in this 
study indicated a significant role of sodium reabsorption in 
proximal tubules in this group of patients and confirmed the 
key role of RNaprox in the pathogenesis of the sodium-sensitivity 
of hypertension. Notably, in both studies mentioned above, 
no relationship between RNadist and the sodium-sensitivity 
of hypertension was found, which was particularly reflected 
by a lack of compensatory RNadist decrease in patients with 
elevated RNaprox. In a recently published report, Zou et al. [51] 
analysed a large group of patients with untreated hypertension 
followed-up in China. Despite revealing no correlation of FELi 
and FDRNa with BP parameters obtained both by conventional 
measurements and ambulatory BP monitoring in the whole 
study group, these authors observed significant correlation 
of daily dietary sodium intake and FELi with respect to BP 
parameters, thus indicating a modulatory effect of dietary 
sodium intake on the balance of renal mechanisms of sodium 
regulation and BP.
These very interesting studies may be the basis for an as-
sumption that in patients with sodium-sensitive hypertension, 
we observe a paradoxical renal sodium retention in case of 
sodium overload and a tendency to increased sodium loss in 
case of its deficiency. This observation is extremely important 
in the context of an increasing problem of hyponatremia in 
the general population (including patients with hyperten-
sion and elderly persons) [52, 53]. Perhaps the patients with 
sodium-sensitive hypertension may be particularly vulnerable 
to hypotension in cases of sodium restriction (especially when 
treated with diuretics causing high excretion of sodium). The 
uncontrolled episodes of hypotension resulting in organ hy-
poperfusion are presumed to be one of the important causes 
of ineffectiveness of an ‘aggressive’ antihypertensive treat-
ment (aimed at achieving low target BP levels) seen in many 
randomised controlled trials. Perhaps this might also explain 
the reports on equivocal influence of sodium restriction on 
the prognosis in patients with hypertension [54].
However, when interpreting these studies one must 
bear in mind other mechanisms regulating the reabsorption 
of lithium, which might be of little importance in physi-
ological conditions but may become apparent in ‘extreme’ 
situations. Vasopressin increases the reabsorption of lithium 
in the distal parts of the nephron; thus a major restriction of 
sodium causing hyponatremia, decrease of plasma osmolality 
and inhibition of ADH secretion may potentially increase the 
excretion of lithium due to the inhibition of its reabsorption 
in distal tubules, which leads to the underestimation of the 
actual reabsorption of sodium in proximal tubules [55].
In recent years, the team of scientists directed by Jan 
Staessen has published several papers on sodium sensitivity 
of hypertension and cardiovascular remodelling including 
the methodology of measurements using endogenous lithium 
clearance. Seidlerova et al. [35] in a paper published in the 
journal ‘Hypertension’ in 2006 analysed the relationship 
between various phenotypes of renal sodium turnover and 
BP and elastic properties of large arteries. The authors stud-
ied 1,069 untreated persons from the general population in 
whom they performed conventional BP measurements and 
ultrasonographic measurements of the diameter, compliance 
and distensibility of the brachial, femoral and carotid arter-
ies. They found a correlation between selected parameters of 
stiffness and remodelling of muscular and elastic arteries and 
the RNaprox and RNadist values. In another study, Jin et al. [56] 
analysed the relationship between sodium turnover and pa-
rameters of left ventricular hypertrophy. The study revealed an 
independent increase of the left ventricular mass index related 
to increased 24-h urinary sodium excretion. The authors also 
analysed the influence of elevated RNaprox and RNadist on left 
ventricular mass index increase, but they found no statistically 
significant correlation of these parameters.
LIMITATIONS OF THE METHOD
Endogenous lithium clearance is currently regarded as the 
most accurate method of the assessment of renal sodium 
metabolism, although it has some limitations discussed in 
the literature.
The principal confounder that limits the use of this 
method, both in daily practice and research, is the influence 
of concomitant antihypertensive drugs, particularly diuretics 
and inhibitors of RAA. While the temporary discontinuation of 
diuretics for several days before the planned study in patients 
with well-controlled hypertension and no coexisting heart 
failure does not seem problematic in the majority of cases, the 
discontinuation of the RAA inhibitors may be controversial. 
Nevertheless, the results of the studies conducted to date sug-
gest that in some situations, e.g. in patients with high dietary 
sodium consumption, it may be unnecessary. Burnier et al. [44] 
in the study mentioned above demonstrated a direct correlation 
of the activity of the RAA system (which is significantly reduced 
in patients consuming a high-sodium diet) and the magnitude 
of the effects of RAA inhibitors, which is significantly reduced in 
persons consuming a high-sodium diet. Moreover, Chiolero et 
al. [50] observed no differences of PRA and serum aldosterone 
levels in patients in the respective tertiles of sodium-sensitivity 
of hypertension, consuming either a low-sodium diet or (and 
particularly) a high-sodium diet. These results may indicate 
that the observed differences of RNaprox between the tertiles 
are completely independent of the activity of the RAA system. 
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Nevertheless, the effects of ACE inhibitors and sartans on 
RNadist values seem to be direct and unquestioned [44].
Another factor whose influence on the test results has 
been commonly implicated is a (minor) lithium reabsorption 
taking place also in the Henle’s loop. The reabsorption in this 
part of the nephron is estimated at 7%, which makes approxi-
mately one tenth of the reabsorbed lithium [22]. Neverthe-
less, the reabsorption of lithium in the distal tubules, which 
was observed in animal models, has not been confirmed in 
humans. The factors that may predispose to increased reab-
sorption of lithium beyond the proximal tubules include very 
low dietary sodium intake, low renal perfusion pressure, and 
altered vasopressin activity. Finally, it must be remembered 
that endogenous lithium clearance is an indirect measure of 
sodium reabsorption in renal tubules. 
CONCLUSIONS
Numerous studies on animal models as well as epidemiologi-
cal and clinical studies have demonstrated that in clinically 
stable patients endogenous lithium clearance is a reliable and 
repeatable tool for the assessment of renal sodium turnover. 
Currently, compared to all the available assays, endogenous 
lithium clearance is perceived as the most accurate method of 
the assessment of renal reabsorption of sodium, and its results 
directly reflect the GFR values. It also allows the avoidance of 
a measurement bias resulting from variable renal perfusion 
and incomplete 24-h urine collections [34]. 
The increasing number of publications on this method 
proves that endogenous lithium clearance is becoming an 
effective and widely available tool to be used in studies on 
the pathogenesis of primary hypertension and its target or-
gan complications.
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from the National Science Centre of Poland (Grant no.: 
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